Diagnosis and treatment of persistent and recurrent UTI with negative conventional urine cultures

Dec 11, 2021

Dr Michael Hsieh, MD, PhD and Director of Transitional Urology at Children’s National and George Washington University Hospital, presents a 40 minute presentation followed by questions on the topic of Diagnosis and treatment of persistent and recurrent UTI associated with negative conventional urine cultures.

AUDIENCE

Health Care Professionals including physicians, lab scientists and all mid-level providers. MDs, DOs, RNs, PAs and MLS.

TOPICS

  • The medical opportunity: few doctors are well versed in treating persistent/recurrent UTI yet there is a lot of patient demand

  • What are persistent/recurrent UTI, how they occur and present by symptoms

  • What is the definition of IC (and why are persistent/recurrent UTI often mistaken for IC)

  • Shortcomings of standard culture testing (and causes)

  • How to diagnose persistent/recurrent UTI (different test options and how to use them effectively & also what to do with limited resources)

  • How to treat persistent/recurrent UTI

  • Epidemiology of persistent/recurrent UTI

SCIENTIFIC REFERENCES

References for the lecture can be found in Dr Hsieh’s reading list.

BIOGRAPHY

Dr. Hsieh, MD, PhD, was recruited to Children’s National and the George Washington University to serve as Director of Transitional Urology. He also runs a bladder biology research group and is developing a broader microbiology research program across multiple laboratories.

Dr. Hsieh has been a Recognized Doctor on the Healthgrades Honor Roll and Best Doctors in America. He has been featured several times in the New York Times for his work in robotic surgery and bladder inflammation.

He attended Stanford University and returned to the East Coast for medical school at Thomas Jefferson University. During medical school, Dr. Hsieh also obtained a PhD in immunology and afterwards began exploring what would eventually become his long-term interest - the role of bladder inflammation in urinary tract infections and development of bladder cancer. He completed his urology residency training at the University of California San Francisco and pediatric urology fellowship training at Texas Children’s Hospital. As a pediatric urology fellow, Dr. Hsieh began studying how the commensal microbiome, the collection of naturally occurring, non-pathogenic bacteria in and on our bodies, may prevent urinary tract infections. Following fellowship training, he was an Assistant Professor at Stanford University, where he founded an NIH-funded research group focused on bladder inflammation, urinary tract infections, and bladder cancer. Dr. Hsieh was the Administrative Director for Stanford’s Children’s Hospital Prenatal Urology and Minimally Invasive Surgery Programs.